| 1 |
National Health and Medical Research
Council. Australian Immunisation Handbook 8th Edition National Capital
Printers; Canberra: September 2003. |
| 2 |
Poole PJ, Chacko E, Wood-Baker RWB, Cates
CJ. Influenza vaccine for patients with chronic obstructive pulmonary
disease. The Cochrane Database of Systematic Reviews 2000, Issue 3:
CD002733. |
| 3 |
Singleton A, Pascale Wortley MS, Lu P-J.
Influenza vaccination of persons with cardiovascular disease in the
United States. Tex Heart Inst J 2004; 31: 227. |
| 4 |
Dear K, Holden J, Andrews R, Tatham D.
Vaccines for preventing pneumococcal infection in adults. The Cochrane
Database of Systematic Reviews 2003, Issue 3: CD000422. |
| 5 |
Lucero MG, Dulalia VE, Parreno RN, Lim-Quianzon
DM, Nohynek H, Makela H, Williams G. Pneumococcal conjugate vaccines for
preventing vaccine-type invasive pneumococcal disease and pneumonia with
consolidation on x-ray in children under two years of age. The Cochrane
Database of Systematic Reviews 2004, Issue 3: CD004977. |
| 6 |
Cates CJ, Jefferson TO, Bara AI, Rowe BH.
Vaccines for preventing influenza in people with asthma. The Cochrane
Database of Systematic Reviews 2003, Issue 4: CD000364.
|
| 7 |
McKenzie DK, Frith PA, Burdon JG, Town GI;
Australian Lung Foundation; Thoracic Society of Australia and New
Zealand. The COPDX Plan: Australian and New Zealand Guidelines for the
management of Chronic Obstructive Pulmonary Disease 2003. Med J Aust.
2003; 178 (Suppl): S1-S40. |
| 8 |
Wongsurakiat P, Maranetra KN, Wasi C, et
al. Acute respiratory illness in patients with COPD and the
effectiveness of influenza vaccination: a randomized controlled study.
Chest 2004; 125: 2011-20. |
| 9 |
Siscovick DS, Raghunathan TE, Lin D, et
al. Influenza vaccination and the risk of primary cardiac arrest. Am J
Epidemiol 2000; 152: 674-77. |
| 10 |
Colquhoun AJ, Nicholson KG, Botha JL, et
al. Effectiveness of influenza vaccine in reducing hospital admissions
in people with diabetes. Epidemiol Infect 1997; 119: 335-41. |
| 11 |
Wang CS, Wang ST, Lai CT, et al. Reducing
major cause-specific hospitalisation rates and shortening hospital stays
after influenza vaccination. Clin Infect Dis 2004; 39: 1604-10. |
| 12 |
Nichol KL, Nordin J, Mullooly J, et al.
Influenza vaccination and reduction in hospitalizations for cardiac
disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-32. |
| 13 |
Demicheli V, Rivetti D, Deeks JJ, Jefferson
TO. Vaccines for preventing influenza in healthy adults. The Cochrane
Database of Systematic Reviews 2004, Issue 3: CD001269. |
| 14 |
Johnston SL, Pattemore PK, Sanderson S, et
al. Community study of the role of viral infections in exacerbations of
asthma in 9-11 year old children. BMJ 1995; 310: 1225-28. |
| 15 |
Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH,
et al. Randomised, placebo-controlled crossover trial on effect of
inactivated influenza vaccine on pulmonary function in asthma. Lancet
1998; 351: 326-31. |
| 16 |
American Lung Association and Asthma
Clinical Research Centers. The safety of inactivated influenza vaccine
in adults and children with asthma. N Engl J Med 2001; 345: 1529-36. |
| 17 |
Bueving HJ, Bernsen RM, de Jongste JC, et
al. Influenza vaccination in children with asthma: randomized
doubleblind placebo-controlled trial. Am J Respir Crit Care Med 2004;
169: 488-93. |
| 18 |
Wongsurakiat P, Maranetra KN,
Gulprasutdilog P, et al. Adverse effects associated with influenza
vaccination in patients with COPD: a randomized controlled study.
Respirology 2004; 9: 550-56. |
| 19 |
Meyers DG. Myocardial infarction, stroke
and sudden cardiac death may be prevented by influenza vaccination. Curr
Atheroscler Rep 2003; 5: 146-49. |
| 20 |
Smeeth L, Thomas SL, Hall AJ, et al. Risk
of myocardial infarction and stroke after acute infection or
vaccination. N Engl J Med 2004; 351: 2611-18. |
| 21 |
Madjid M, Naghavi M, Litovsky S, et al.
Influenza and cardiovascular disease: a new opportunity for prevention
and the need for further studies. Circulation 2003; 108: 2730-36. |
| 22 |
Naghavi M, Barlas Z, Siadaty S, et al.
Association of influenza vaccination and reduced risk of recurrent
myocardial infarction. Circulation 2000; 102: 3039-45. |
| 23 |
Lavallée P, Perchaud V, Gautier-Bertrand M,
et al. Association between influenza vaccination and reduced risk of
brain infarction. Stroke. 2002; 33:513-518. |
| 24 |
Gurfinkel EP, de la Fuente RL. Influenza
and Cardiovascular Disease Two-Year Follow-Up of the FLU Vaccination
Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J 2004; 31:
28-32. |
| 25 |
Diepersloot RJ, Bouter KP, Hoeksrta JB.
Influenza infection and diabetes mellitis. Case for annual vaccination.
Diabetes Care 1990; 13: 876-82. |
| 26 |
Smith SA, Poland GA. American Diabetes
Association: Influenza and pneumococcal immunization in diabetes.
Diabetes Care. 2004; 27 (Suppl 1) :S111-3. |
| 27 |
Sheikh A, Alves B, Dhami S. Pneumococcal
vaccine for asthma. The Cochrane Database of Systematic Reviews 2002,
Issue 1: CD002165. |
| 28 |
Watson M, Bayley K, Bell JM, et al.
Laboratory surveillance of invasive pneumococcal disease in Australia in
2001 to 2002: implications for vaccine serotype coverage. Commun Dis
Intell 2003; 27: 478-87. |
| 29 |
Fedson DS. The clinical effectiveness of
pneumococcal vaccination: a brief review. Vaccine. 1999; 17 (Suppl 1):
S85-90. |
| 30 |
Conaty S. Watson L. Dinnes J. Waugh N. The
effectiveness of pneumococcal polysaccharide vaccines in adults: a
systematic review of observational studies and comparison with results
from randomised controlled trials. Vaccine 2004; 22: 3214-24. |
| 31 |
Melegaro A, Edmunds WJ. The 23-valent
pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the
elderly: a comparison of meta-analyses. Eur J Epidemiol. 2004; 19:
353-63.
|
| 32 |
Watson L, Wilson BJ, Waugh N. Pneumococcal
polysaccharide vaccine: a systematic review of clinical effectiveness in
adults. Vaccine 2002; 20: 2166-73. |
| 33 |
Cornu C, Yzebe D, Leophonte P, et al.
Efficacy of pneumococcal polysaccharide vaccine in immunocompetent
adults: a meta-analysis of randomized trials. Vaccine 2001; 19: 4780-90. |
| 34 |
Fine MJ, Smith MA, Carson CA, et al.
Efficacy of pneumococcal vaccination in adults: a meta-analysis of
randomised controlled trials. Arch Int Med 1994; 154: 2666-77. |
| 35 |
Moore RA, Wiffen PJ, Lipsky BA. Are the
pneumococcal polysaccharide vaccines effective? Metaanalysis of the
prospective trials. BMC Fam Pract 2000; 1: 1. |
| 36 |
Hutchison BG, Oxman AD, Shannon HS, et al.
Clinical effectiveness of pneumococcal vaccine. Can Fam Phys 1999; 45:
2381-93. |
| 37 |
Straetemans M, Sanders EA, Veenhoven RH, et
al. Pneumococcal vaccines for preventing otitis media. Cochrane Database
Syst Rev 2002; (2): CD001480. |
| 38 |
Schuller DE. Prophylaxis of otitis media in
asthmatic children. Pediatric Infectious Disease 1983; 2: 280-3.
|
| 39 |
Center for Disease Control. Prevention of
Pneumococcal Disease: Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR 1997; 46: 1-24. |
| 40 |
Australian Government Department of Heath
and Ageing. Population Heath Division. Universal Childhood Pneumococcal
Vaccination Program; National pneumococcal vaccination program for older
Australians; January 2005. http://immunise.health.gov.au/pneumococcal/index.htm. |
| 41 |
Jonsson S, Vidarsson G, Valdimarsson H, et
al. Vaccination of COPD patients with a pneumococcus type 6B tetanus
toxoid conjugate vaccine. Eur Respir J 2002; 20: 813-18. |
| 42 |
Nichol KL. The additive benefits of
influenza and pneumococcal vaccinations during influenza seasons among
elderly persons with chronic lung disease. Vaccine 1999; 17 (Suppl 1):
S91-93. |
| 43 |
Sin DD, McAlister FA, Man SF, et al.
Contemporary management of chronic obstructive pulmonary disease:
scientific review. JAMA. 2003; 290: 2301-12. |
| 44 |
Smith SA, Poland GA: The use of influenza
and pneumococcal vaccines in people with diabetes (technical review).
Diabetes Care 2000; 23: 95-108. |
| 45 |
Butler JC, Beiman RF, Campbell JF, et al.
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current
recommendations. JAMA 1993; 270: 1826-31. |
| 46. |
Talbot TR, Hartert TV, Mitchel E, et al.
Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med
2005; 352: 2082-90. |
